Éclat Pharmaceuticals, LLC – Trademark Portfolio

Entity Type: 16

Éclat Pharmaceuticals, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include VAZCULEP and BLOXIVERZ. The owner is based in Chesterfield, MO.

702 Spirit 40 Park, Suite 108

Chesterfield, MO 63005

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KEPTASO
KEPTASO
Abandoned 2013
BLOXIVERZ
BLOXIVERZ
Registered 2012
NEOVERSA
NEOVERSA
Abandoned 2012
VAZCULEP
VAZCULEP
Registered 2012

Trademark Classifications

Éclat Pharmaceuticals, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Éclat Pharmaceuticals, LLC have?

Éclat Pharmaceuticals, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does Éclat Pharmaceuticals, LLC file in?

Éclat Pharmaceuticals, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Éclat Pharmaceuticals, LLC's most well-known trademarks?

Éclat Pharmaceuticals, LLC's registered trademark portfolio includes well-known marks such as VAZCULEP and BLOXIVERZ. These are among 2 currently registered trademarks in the portfolio.

What is Éclat Pharmaceuticals, LLC's trademark registration success rate?

Éclat Pharmaceuticals, LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.